Literature DB >> 23255147

Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming.

Man Ryul Lee1, Nutan Prasain, Hee-Don Chae, Young-June Kim, Charlie Mantel, Mervin C Yoder, Hal E Broxmeyer.   

Abstract

While most somatic cells undergoing induced pluripotent stem (iPS) cell reprogramming with Yamanaka factors accumulate at stable partially reprogrammed stages, the molecular mechanisms required to achieve full reprogramming are unknown. MicroRNAs (miRNAs) fine-tune mRNA translation and are implicated in reprogramming, but miRNA functional targets critical for complete iPS cell reprogramming remain elusive. We identified methyl-DNA binding domain protein 2 (MBD2) as an epigenetic suppressor, blocking full reprogramming of somatic to iPS cells through direct binding to NANOG promoter elements preventing transcriptional activation. When we overexpressed miR-302 cluster we observed a significant increase in conversion of partial to fully reprogrammed iPS cells by suppressing MBD2 expression, thereby increasing NANOG expression. Thus, expression of exogenous miR-302 cluster (without miR-367) is efficient in attaining a fully reprogrammed iPS state in partially reprogrammed cells by relieving MBD2-mediated inhibition of NANOG expression. Our studies provide a direct molecular mechanism involved in generating complete human iPS cell reprogramming to study disease pathogenesis, drug screening, and for potential cell-based therapies.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23255147      PMCID: PMC3904370          DOI: 10.1002/stem.1302

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  45 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  A protein interaction network for pluripotency of embryonic stem cells.

Authors:  Jianlong Wang; Sridhar Rao; Jianlin Chu; Xiaohua Shen; Dana N Levasseur; Thorold W Theunissen; Stuart H Orkin
Journal:  Nature       Date:  2006-11-08       Impact factor: 49.962

3.  Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract.

Authors:  Christel T Freberg; John Arne Dahl; Sanna Timoskainen; Philippe Collas
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

4.  Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling.

Authors:  E Gluckman; H A Broxmeyer; A D Auerbach; H S Friedman; G W Douglas; A Devergie; H Esperou; D Thierry; G Socie; P Lehn
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

5.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

6.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

7.  Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.

Authors:  H E Broxmeyer; G W Douglas; G Hangoc; S Cooper; J Bard; D English; M Arny; L Thomas; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

8.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

9.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

Review 10.  Mechanisms of disease: methyl-binding domain proteins as potential therapeutic targets in cancer.

Authors:  Owen J Sansom; Kathryn Maddison; Alan R Clarke
Journal:  Nat Clin Pract Oncol       Date:  2007-05
View more
  46 in total

1.  MicroRNAs in regulation of pluripotency and somatic cell reprogramming: small molecule with big impact.

Authors:  Tian Wang; San-bao Shi; Hong-ying Sha
Journal:  RNA Biol       Date:  2013-07-23       Impact factor: 4.652

2.  miR-290/371-Mbd2-Myc circuit regulates glycolytic metabolism to promote pluripotency.

Authors:  Yang Cao; Wen-Ting Guo; Shengya Tian; Xiaoping He; Xi-Wen Wang; Xiaomeng Liu; Kai-Li Gu; Xiaoyu Ma; De Huang; Lan Hu; Yongping Cai; Huafeng Zhang; Yangming Wang; Ping Gao
Journal:  EMBO J       Date:  2015-01-20       Impact factor: 11.598

Review 3.  Cord blood research, banking, and transplantation: achievements, challenges, and perspectives.

Authors:  Hector Mayani; John E Wagner; Hal E Broxmeyer
Journal:  Bone Marrow Transplant       Date:  2019-05-14       Impact factor: 5.483

Review 4.  An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.

Authors:  Manash P Borgohain; Krishna Kumar Haridhasapavalan; Chandrima Dey; Poulomi Adhikari; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

5.  miRNA overexpression induces cardiomyocyte proliferation in vivo.

Authors:  Andrew H Baker; Eva van Rooij
Journal:  Mol Ther       Date:  2013-03       Impact factor: 11.454

6.  Inhibiting HDAC for human hematopoietic stem cell expansion.

Authors:  Hal E Broxmeyer
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

Review 7.  Regulatory factors of induced pluripotency: current status.

Authors:  Wei Zhao; Bo Ning; Chen Qian
Journal:  Stem Cell Investig       Date:  2014-07-22

8.  Comparative gene expression signature of pig, human and mouse induced pluripotent stem cell lines reveals insight into pig pluripotency gene networks.

Authors:  Yajun Liu; Yangyang Ma; Jeong-Yeh Yang; De Cheng; Xiaopeng Liu; Xiaoling Ma; Franklin D West; Huayan Wang
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

9.  MicroRNAomic Transcriptomic Analysis Reveal Deregulation of Clustered Cellular Functions in Human Mesenchymal Stem Cells During in Vitro Passaging.

Authors:  Shuh-Wen Aung; Noor Hayaty Abu Kasim; Shamsul Azlin Ahmad Shamsuddin; Thamil Selvee Ramasamy
Journal:  Stem Cell Rev Rep       Date:  2020-02       Impact factor: 5.739

10.  Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells.

Authors:  Yu Lu; Yuin-Han Loh; Hu Li; Marcella Cesana; Scott B Ficarro; Jignesh R Parikh; Nathan Salomonis; Cheng-Xu Delon Toh; Stelios T Andreadis; C John Luckey; James J Collins; George Q Daley; Jarrod A Marto
Journal:  Cell Stem Cell       Date:  2014-05-08       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.